PURPOSE: To investigate cerebrospinal fluid (CSF) dynamics in the aqueduct of Sylvius in multiple sclerosis (MS) patients and healthy controls (HC) using cine phase contrast imaging. MATERIALS AND METHODS: In all, 67 MS patients (48 relapsing-remitting [RR] and 19 secondary-progressive [SP]), nine patients with clinically isolated syndrome (CIS), and 35 age- and sex-matched HC were examined. CSF flow and velocity measures were quantified using a semiautomated method and compared with clinical and magnetic resonance imaging (MRI) disease outcomes. RESULTS: Significantly decreased CSF net flow was detected in MS patients compared to HC (-3.7 vs. -7.1 μL/beat, P = 0.005). There was a trend for increased net positive flow between SP, RR, and CIS patients. Altered CSF flow and velocity measures were associated with more severe T1 and T2 lesion volumes, lateral and fourth ventricular volumes, and third ventricular width in MS and CIS patients (P < 0.01 for all). In CIS patients, conversion to clinically definite MS in the following year was related to decreased CSF net flow (P = 0.007). There was a trend between increased annual relapse rate and altered CSF flow/velocity measures in RRMS patients (P < 0.05). CONCLUSION: CSF flow dynamics are altered in MS patients. More severe clinical and MRI outcomes in RRMS and CIS patients relate to altered CSF flow and velocity measures.
PURPOSE: To investigate cerebrospinal fluid (CSF) dynamics in the aqueduct of Sylvius in multiple sclerosis (MS) patients and healthy controls (HC) using cine phase contrast imaging. MATERIALS AND METHODS: In all, 67 MS patients (48 relapsing-remitting [RR] and 19 secondary-progressive [SP]), nine patients with clinically isolated syndrome (CIS), and 35 age- and sex-matched HC were examined. CSF flow and velocity measures were quantified using a semiautomated method and compared with clinical and magnetic resonance imaging (MRI) disease outcomes. RESULTS: Significantly decreased CSF net flow was detected in MS patients compared to HC (-3.7 vs. -7.1 μL/beat, P = 0.005). There was a trend for increased net positive flow between SP, RR, and CIS patients. Altered CSF flow and velocity measures were associated with more severe T1 and T2 lesion volumes, lateral and fourth ventricular volumes, and third ventricular width in MS and CIS patients (P < 0.01 for all). In CIS patients, conversion to clinically definite MS in the following year was related to decreased CSF net flow (P = 0.007). There was a trend between increased annual relapse rate and altered CSF flow/velocity measures in RRMS patients (P < 0.05). CONCLUSION: CSF flow dynamics are altered in MS patients. More severe clinical and MRI outcomes in RRMS and CIS patients relate to altered CSF flow and velocity measures.
Authors: M Varosanec; T Uher; D Horakova; J Hagemeier; N Bergsland; M Tyblova; Z Seidl; M Vaneckova; J Krasensky; M G Dwyer; E Havrdova; R Zivadinov Journal: AJNR Am J Neuroradiol Date: 2015-06-25 Impact factor: 3.825
Authors: Khader M Hasan; John A Lincoln; Flavia M Nelson; Jerry S Wolinsky; Ponnada A Narayana Journal: Magn Reson Imaging Date: 2014-12-05 Impact factor: 2.546
Authors: Eleuterio Francisco Toro; Morena Celant; Qinghui Zhang; Christian Contarino; Nivedita Agarwal; Andreas Linninger; Lucas Omar Müller Journal: Int J Numer Method Biomed Eng Date: 2021-10-19 Impact factor: 2.648
Authors: David S Wack; Michael G Dwyer; Niels Bergsland; Deepa Ramasamy; Carol Di Perri; Laura Ranza; Sara Hussein; Christopher Magnano; Kevin Seals; Robert Zivadinov Journal: BMC Med Imaging Date: 2013-09-03 Impact factor: 1.930
Authors: Tomas Uher; Dana Horakova; Niels Bergsland; Michaela Tyblova; Deepa P Ramasamy; Zdenek Seidl; Manuela Vaneckova; Jan Krasensky; Eva Havrdova; Robert Zivadinov Journal: Neuroimage Clin Date: 2014-09-28 Impact factor: 4.881